To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCBL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
475 supporting clones for gene CCBL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC397531 testis .a 1 to 560 1 to 560   tiling clone,   560/560
(100 %)
0 diff
(100 %id)
DC424120 mammary gland .a 68 to 875 1 to 811       811/811
(100 %)
4 diff
(99.6 %id)
NM_001008661.2   .a 68 to 2219 1 to 2152 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2152/2152
(100 %)
0 diff
(100 %id)
DC359333 lung .a 92 to 650 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
BM728982 eye, fetal eye .a 107 to 787 1 to 682     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 682/682
(100 %)
1 diff
(99.9 %id)
DC386937   .a 226 to 794 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
AY028624   .a 248 to 2212 1 to 1965 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1965/1965
(100 %)
0 diff
(100 %id)
N39655 melanocyte .a 248 to 748 1 to 504       504/534
(94 %)
12 diff
(97.8 %id)
DC320182 brain .a 255 to 816 1 to 562       562/562
(100 %)
2 diff
(99.7 %id)
DC338769 subthalamic nucleus .a 256 to 802 10 to 556       547/547
(100 %)
1 diff
(99.9 %id)
DC390053 Spleen .a 256 to 827 9 to 580       572/572
(100 %)
1 diff
(99.9 %id)
DC407407 thymus .a 256 to 805 8 to 557       550/550
(100 %)
0 diff
(100 %id)
DC326491 caudate nucleus .a 257 to 816 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC428626   .a 257 to 828 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BG469039 adenocarcinoma cell line, colon .a 262 to 850 1 to 597       597/598
(99 %)
24 diff
(96.0 %id)
DC419184 stomach, tumor tissue .a 283 to 850 1 to 568       568/568
(100 %)
0 diff
(100 %id)
DC304689 cerebellum .a 315 to 877 1 to 563       563/563
(100 %)
0 diff
(100 %id)
AK315917 cerebellum .a 371 to 1916 1 to 1546 exact     1546/1546
(100 %)
0 diff
(100 %id)
DC302628 cerebellum .a 371 to 942 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC360374   .a 371 to 921 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AK301326 stomach .a 381 to 1992 1 to 1612 exact     1612/1612
(100 %)
1 diff
(100.0 %id)
BJ991478 hepatoblastoma .a 381 to 963 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC392657 stomach .a 381 to 926 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DC357073 heart .a 393 to 857 1 to 465       465/465
(100 %)
0 diff
(100 %id)
DC414528 trachea .a 393 to 976 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
CD357856 Pooled-Skin .a 396 to 984 1 to 592       592/772
(76 %)
6 diff
(99.3 %id)
DC314827 amygdala .a 399 to 973 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BI334478 cervical carcinoma cell line, cervix .a 403 to 1158 1 to 756       756/761
(99 %)
9 diff
(98.9 %id)
DC297813   .a 408 to 972 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
CN255370 embryonic stem cells, DMSO-treated H9 cellline .a 409 to 824 8 to 423       416/423
(98 %)
7 diff
(98.4 %id)
CN255376 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 412 to 1104 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
BQ880027 dorsal root ganglia .a 413 to 1283 1 to 874       874/876
(99 %)
18 diff
(98.0 %id)
BF676127 Prostate .a 415 to 1112 1 to 693       693/891
(77 %)
29 diff
(96.8 %id)
CR608245 Placenta Cot 25-normalized .a 417 to 2176 1 to 1760 exact     1760/1760
(100 %)
0 diff
(100 %id)
AL544156 placenta, Placenta Cot 25-normalized .a 417 to 1262 1 to 848   fully sequenced,   848/848
(100 %)
3 diff
(99.7 %id)
BF977456 melanotic melanoma, high MDR, skin .a 418 to 1117 1 to 703       703/812
(86 %)
22 diff
(97.3 %id)
CB985647 Pooled-Glandular .a 424 to 1228 1 to 809       809/812
(99 %)
8 diff
(99.1 %id)
CN255377 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 465 to 1081 1 to 617       617/617
(100 %)
0 diff
(100 %id)
CN255375 embryonic stem cells, cell lines H1, H7, andH9 .a 467 to 1081 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
AL570373 placenta, Placenta Cot 25-normalized .a 1201 to 2176 977 to 1   fully sequenced,   977/977
(100 %)
3 diff
(99.7 %id)
BM681933 eye, fetal eye .a 1547 to 2212 684 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 666/666
(100 %)
0 diff
(100 %id)
BJ991479 hepatoblastoma .a 1590 to 2129 540 to 1       540/540
(100 %)
0 diff
(100 %id)
NM_001008662.2   .b 1 to 2052 1 to 2052 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2052/2052
(100 %)
0 diff
(100 %id)
DA010727 adrenal gland .b 11 to 588 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
DA079810 cerebellum .b 26 to 573 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DB002537 breast, tumor tissue .b 27 to 560 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BX462826 T cells (Jurkat cell line) .b 128 to 1060 1 to 933       933/940
(99 %)
4 diff
(99.6 %id)
DA538542 Kidney .b 160 to 735 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BX443336 B cells (Ramos cell line) .b 161 to 1008 1 to 848       848/848
(100 %)
5 diff
(99.5 %id)
DA690968   .b 162 to 730 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DB167361 kidney, tumor tissue .b 163 to 729 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BX486890   .b 169 to 716 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
DA942836 Spleen .b 172 to 758 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
CR988865 T-Lymphocytes .b 181 to 827 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BG177464 lymph, lymphoma, cell line .b 184 to 916 1 to 721       721/935
(77 %)
26 diff
(97.3 %id)
BM918630 pooled pancreas and spleen .b 184 to 1240 19 to 1087       1069/1112
(96 %)
37 diff
(96.7 %id)
AK057176 stomach .b 185 to 2045 1 to 1861 exact tiling clone, available from FLJ,   1861/1861
(100 %)
0 diff
(100 %id)
DA420497 cervix .b 185 to 734 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA962466 stomach .b 186 to 698 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA948965 Spleen .b 188 to 745 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB013864 esophageal, tumor tissue .b 188 to 762 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA813842   .b 189 to 741 11 to 563   capped   553/553
(100 %)
0 diff
(100 %id)
DB020530 testis .b 198 to 751 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
F13166 brain, total brain .b 199 to 519 1 to 320       320/320
(100 %)
1 diff
(99.7 %id)
R54205 whole brain .b 201 to 580 1 to 382       382/469
(81 %)
13 diff
(97.3 %id)
BM836676 Ascites, stomach .b 201 to 626 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
DA937057 Spleen .b 201 to 785 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BE543407 cervical carcinoma cell line, cervix .b 202 to 941 1 to 737       734/872
(84 %)
20 diff
(97.8 %id)
DA673863   .b 202 to 796 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA375336 thalamus .b 205 to 759 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB000067 breast, tumor tissue .b 205 to 750 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA903548   .b 207 to 766 2 to 567   capped   568/566
(100 %)
8 diff
(98.6 %id)
TI_57197362   .b 209 to 1029 55 to 875       822/875
(93 %)
12 diff
(98.7 %id)
W32140 parathyroid gland, parathyroid tumor .b 215 to 629 1 to 426       426/426
(100 %)
14 diff
(96.8 %id)
BI819474 pooled brain, lung, testis .b 216 to 1029 1 to 814       814/814
(100 %)
6 diff
(99.3 %id)
BI912359 leukocyte .b 217 to 929 62 to 763       702/764
(91 %)
13 diff
(98.3 %id)
TI_57235589   .b 217 to 929 62 to 763       702/764
(91 %)
13 diff
(98.3 %id)
DA921111 small intestine .b 221 to 801 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
CX751399 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 224 to 941 1 to 712     Submitted on the opposite strand 712/716
(99 %)
7 diff
(99.1 %id)
BI911865 leukocyte .b 234 to 997 32 to 796       765/796
(96 %)
13 diff
(98.4 %id)
DA618900   .b 234 to 817 2 to 586   capped   585/586
(99 %)
1 diff
(99.9 %id)
TI_57232527   .b 234 to 997 32 to 796       765/796
(96 %)
13 diff
(98.4 %id)
BM477115 lymph, lymphoma, cell line .b 237 to 730 1 to 489       489/1080
(45 %)
10 diff
(99.1 %id)
BM843644 lymph node, stomach .b 238 to 708 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
BM843229 lymph node, stomach .b 238 to 881 1 to 644       644/644
(100 %)
3 diff
(99.6 %id)
BF571248 melanotic melanoma, high MDR, skin .b 308 to 796 1 to 495       495/1051
(47 %)
24 diff
(97.8 %id)
BI561510 testis .b 309 to 1028 1 to 720       720/720
(100 %)
8 diff
(98.9 %id)
TI_44350729   .b 310 to 1028 123 to 841       719/841
(85 %)
10 diff
(98.9 %id)
BU959182 mixed (pool of 40 RNAs) .b 329 to 1131 1 to 805       805/810
(99 %)
16 diff
(98.1 %id)
CB128547 cervix, Uterine .b 330 to 945 1 to 616       616/619
(99 %)
2 diff
(99.7 %id)
DR762529 embryonic stem .b 330 to 1226 1 to 898       898/898
(100 %)
7 diff
(99.3 %id)
AA194125 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 338 to 912 7 to 594       586/594
(98 %)
30 diff
(95.0 %id)
DB058006 testis .b 339 to 871 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
DA004239   .b 340 to 908 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CF597422 ovary .b 343 to 1028 5 to 696       692/786
(88 %)
28 diff
(96.5 %id)
BI859979 breast, mammary adenocarcinoma, cell line .b 345 to 1044 1 to 701       701/702
(99 %)
3 diff
(99.6 %id)
TI_57188715   .b 345 to 1044 53 to 753       701/702
(99 %)
3 diff
(99.6 %id)
AA313907 colon .b 350 to 580 1 to 231       231/231
(100 %)
0 diff
(100 %id)
CD689198 normal nasopharynx .b 350 to 908 32 to 592       561/592
(94 %)
20 diff
(96.7 %id)
BM548095 brain, hippocampus .b 350 to 1236 15 to 909       895/1109
(80 %)
22 diff
(98.1 %id)
BF028520 bladder, carcinoma, cell line .b 352 to 1011 1 to 648       648/859
(75 %)
17 diff
(98.1 %id)
BQ719000 sympathetic trunk .b 352 to 944 2 to 594       593/1006
(58 %)
9 diff
(99.2 %id)
DA603744   .b 353 to 863 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
AA343862 gall bladder .b 369 to 694 1 to 326       326/326
(100 %)
0 diff
(100 %id)
TI_57162259   .b 369 to 1092 26 to 748       726/748
(97 %)
11 diff
(98.6 %id)
AW965076   .b 370 to 1060 1 to 692       692/719
(96 %)
11 diff
(98.5 %id)
AA490352 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 374 to 746 1 to 372       372/372
(100 %)
6 diff
(98.4 %id)
BX403613 placenta .b 375 to 1223 1 to 852   fully sequenced,   849/849
(100 %)
5 diff
(99.5 %id)
CR614429 Placenta Cot 25-normalized .b 375 to 1937 1 to 1563 exact     1563/1563
(100 %)
0 diff
(100 %id)
CR615627 placenta .b 375 to 1969 1 to 1595 exact     1595/1595
(100 %)
0 diff
(100 %id)
AL544547 placenta, Placenta Cot 25-normalized .b 375 to 1095 1 to 721   fully sequenced,   721/721
(100 %)
0 diff
(100 %id)
BI832730 pooled pancreas and spleen .b 375 to 1092 1 to 717       717/717
(100 %)
6 diff
(99.2 %id)
EC557523 Prostate .b 383 to 484 8 to 109       102/109
(93 %)
6 diff
(94.5 %id)
EC556312 Prostate .b 386 to 482 1 to 97       97/97
(100 %)
0 diff
(100 %id)
EC557071 Prostate .b 386 to 484 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BE870761 adenocarcinoma, colon .b 417 to 1137 1 to 722       722/767
(94 %)
32 diff
(95.9 %id)
BC000819 Placenta, choriocarcinoma .b 528 to 2045 1 to 1518   available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1518/1518
(100 %)
0 diff
(100 %id)
BE536508 cervix .b 548 to 1236 1 to 689       689/770
(89 %)
9 diff
(98.9 %id)
CN255378 embryonic stem cells, DMSO-treated H9 cellline .b 654 to 1147 1 to 494       494/494
(100 %)
5 diff
(99.0 %id)
BE568154 bladder, carcinoma, cell line .b 669 to 1384 1 to 713       713/750
(95 %)
22 diff
(97.1 %id)
CN255373 embryonic stem cells, DMSO-treated H9 cellline .b 689 to 996 1 to 308       308/308
(100 %)
0 diff
(100 %id)
CB052887 leiomyosarcoma, soft tissue .b 689 to 851 10 to 172     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 163/172
(94 %)
6 diff
(96.6 %id)
AF091090   .b 707 to 1971 9 to 1274   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1266/1266
(100 %)
3 diff
(99.8 %id)
BX089720 melanocyte .b 708 to 1407 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
N44540 melanocyte .b 708 to 1025 1 to 319       319/321
(99 %)
8 diff
(97.6 %id)
W95847 heart .b 726 to 1343 1 to 610       610/677
(90 %)
10 diff
(98.6 %id)
CN255379 embryonic stem cells, DMSO-treated H9 cellline .b 731 to 1213 10 to 492       483/492
(98 %)
0 diff
(100 %id)
BF035401 adenocarcinoma, ovary .b 752 to 1467 1 to 708       708/711
(99 %)
16 diff
(97.8 %id)
CR450282   .b 770 to 1293 1 to 525       525/525
(100 %)
4 diff
(99.3 %id)
CV024454 mixed .b 770 to 1391 1 to 622       622/623
(99 %)
1 diff
(99.9 %id)
EC463734 Prostate .b 793 to 912 118 to 1       118/118
(100 %)
3 diff
(97.5 %id)
EC572711 Prostate .b 793 to 905 119 to 11       109/119
(91 %)
2 diff
(98.4 %id)
AA773855 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 798 to 1235 1 to 437       437/437
(100 %)
4 diff
(99.1 %id)
BG169571 hypernephroma, cell line, Kidney .b 808 to 1486 1 to 673       673/674
(99 %)
12 diff
(98.3 %id)
BQ316320 colon .b 818 to 1356 552 to 16       537/575
(93 %)
1 diff
(99.9 %id)
BQ373190 prostate_tumor .b 849 to 1091 10 to 252       243/252
(96 %)
6 diff
(97.7 %id)
BQ373191 prostate_tumor .b 849 to 1091 10 to 252       243/252
(96 %)
6 diff
(97.7 %id)
BQ373193 prostate_tumor .b 849 to 1091 243 to 1       243/255
(95 %)
0 diff
(100 %id)
BQ373194 prostate_tumor .b 849 to 1091 10 to 252       243/252
(96 %)
7 diff
(97.3 %id)
BI061469 uterus_tumor .b 863 to 1068 12 to 224       213/251
(84 %)
19 diff
(92.5 %id)
BM832273 stomach .b 916 to 1138 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
BM839741 stomach .b 916 to 1230 1 to 315       315/315
(100 %)
6 diff
(98.1 %id)
AA224242   .b 917 to 1346 1 to 427       427/428
(99 %)
3 diff
(99.3 %id)
BM713939 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 938 to 1523 1 to 586   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 586/586
(100 %)
5 diff
(99.2 %id)
BQ350428 head_neck .b 949 to 1321 1 to 379       379/379
(100 %)
15 diff
(96.1 %id)
CV347017 colon_ins .b 967 to 1562 598 to 5     Submitted on the opposite strand 594/598
(99 %)
3 diff
(99.5 %id)
EC540463 Prostate .b 977 to 1068 94 to 4       91/94
(96 %)
7 diff
(92.6 %id)
AL570634 placenta, Placenta Cot 25-normalized .b 1034 to 1937 907 to 1   fully sequenced,   907/907
(100 %)
7 diff
(99.3 %id)
BM727668 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1064 to 1655 1 to 592   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 592/592
(100 %)
1 diff
(99.9 %id)
BG695921 skin .b 1089 to 1903 1 to 813       813/814
(99 %)
3 diff
(99.7 %id)
BX414117 B cells (Ramos cell line) .b 1094 to 1956 867 to 5       863/868
(99 %)
2 diff
(99.8 %id)
AA449047   .b 1131 to 1721 1 to 589   fully sequenced,   589/589
(100 %)
2 diff
(99.7 %id)
T64590 Liver .b 1160 to 1528 377 to 2       376/378
(99 %)
7 diff
(98.2 %id)
BQ267371 insulinoma, Pancreas .b 1176 to 1735 8 to 567       560/567
(98 %)
6 diff
(99.0 %id)
CK825317 insulinoma, Pancreas .b 1176 to 1726 8 to 558       551/558
(98 %)
6 diff
(99.0 %id)
CN255372 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1190 to 1757 1 to 568       568/568
(100 %)
4 diff
(99.3 %id)
BE173004 head_neck .b 1192 to 1443 3 to 252       250/258
(96 %)
13 diff
(95.0 %id)
BX453881 placenta .b 1193 to 1962 773 to 8   fully sequenced,   766/773
(99 %)
4 diff
(99.5 %id)
BM821099 stomach .b 1214 to 1692 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
AA636112 Ewing's sarcoma .b 1228 to 1527 300 to 1       300/311
(96 %)
0 diff
(100 %id)
BE835820 prostate_normal .b 1321 to 1701 393 to 10       383/393
(97 %)
3 diff
(99.3 %id)
BF847444 lung_normal .b 1330 to 1733 404 to 1     Submitted on the opposite strand 404/404
(100 %)
8 diff
(98.1 %id)
BE767555 placenta_normal .b 1389 to 1679 293 to 5       289/293
(98 %)
0 diff
(100 %id)
AA843882 parathyroid gland, parathyroid tumor .b 1415 to 2046 637 to 6       632/945
(66 %)
19 diff
(98.0 %id)
W94950 heart .b 1416 to 1972 548 to 1       548/587
(93 %)
17 diff
(97.2 %id)
AI376667 pooled .b 1416 to 1968 551 to 1       551/621
(88 %)
9 diff
(98.6 %id)
BX414309 T cells (Jurkat cell line) .b 1417 to 2038 628 to 4       625/628
(99 %)
17 diff
(97.3 %id)
TI_57183279   .b 1438 to 2040 33 to 640       608/1060
(57 %)
15 diff
(98.6 %id)
BQ272605 insulinoma, Pancreas .b 1439 to 2045 622 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 607/607
(100 %)
0 diff
(100 %id)
BI769862 pooled lung and spleen .b 1441 to 2040 1 to 605       605/1025
(59 %)
9 diff
(99.2 %id)
AI887639 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1445 to 2045 617 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 600/600
(100 %)
8 diff
(98.7 %id)
AI934333 Kidney .b 1445 to 2040 600 to 4       597/600
(99 %)
2 diff
(99.7 %id)
AW779793 Kidney .b 1448 to 2046 599 to 1       599/599
(100 %)
11 diff
(98.2 %id)
AA772350 parathyroid gland, parathyroid tumor .b 1451 to 2045 617 to 22   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 596/596
(100 %)
4 diff
(99.4 %id)
CB052886 leiomyosarcoma, soft tissue .b 1460 to 2045 607 to 24   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 584/584
(100 %)
2 diff
(99.7 %id)
BM676555 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1462 to 2045 602 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 584/584
(100 %)
0 diff
(100 %id)
AW276629 lung, two pooled squamous cell carcinomas .b 1463 to 2051 590 to 2       589/590
(99 %)
3 diff
(99.5 %id)
AA176308   .b 1473 to 1774 1 to 305   fully sequenced,   305/305
(100 %)
4 diff
(98.7 %id)
AA176322   .b 1474 to 1649 1 to 176   fully sequenced,   176/176
(100 %)
1 diff
(99.5 %id)
AW341497 pooled .b 1475 to 2046 573 to 2       572/573
(99 %)
1 diff
(99.9 %id)
AI142809 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1477 to 1972 493 to 1       493/495
(99 %)
3 diff
(99.4 %id)
BE465473 Kidney .b 1490 to 2051 572 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 562/562
(100 %)
0 diff
(100 %id)
AA024433 heart .b 1492 to 1973 485 to 1       485/486
(99 %)
4 diff
(99.2 %id)
AI478599 Kidney .b 1496 to 2052 570 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 557/557
(100 %)
2 diff
(99.7 %id)
AI347246 colon, colon tumor, RER+ .b 1511 to 1968 475 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 458/458
(100 %)
4 diff
(99.2 %id)
AA224243   .b 1515 to 1969 457 to 3       455/458
(99 %)
0 diff
(100 %id)
BE835810 prostate_normal .b 1520 to 1701 200 to 13       188/200
(94 %)
3 diff
(98.5 %id)
DB334445 stomach .b 1532 to 2045 516 to 1       516/516
(100 %)
2 diff
(99.7 %id)
AA772088 parathyroid gland, parathyroid tumor .b 1536 to 2045 522 to 13   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 510/510
(100 %)
0 diff
(100 %id)
DB325201.
matches multiple genes
  .b 1545 to 2045 503 to 1     also hits gene dawfar, fafar, geefar 503/503
(100 %)
2 diff
(99.7 %id)
AI348507 carcinoid, lung .b 1547 to 1967 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI537894 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1553 to 1969 420 to 3       418/420
(99 %)
0 diff
(100 %id)
AA490243 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1563 to 1969 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AI095897 uterus .b 1564 to 2045 493 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 482/482
(100 %)
0 diff
(100 %id)
BE540477 cervix .b 1568 to 2046 1 to 481       481/481
(100 %)
3 diff
(99.4 %id)
AI758105 Kidney .b 1574 to 1971 400 to 1       400/411
(97 %)
11 diff
(97.4 %id)
AA999952 Kidney .b 1578 to 2045 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AA542935 normal prostate, Prostate .b 1580 to 2045 497 to 32   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 466/474
(98 %)
7 diff
(98.6 %id)
AA723873 pooled .b 1584 to 2046 470 to 8       463/470
(98 %)
0 diff
(100 %id)
AI218489 pooled .b 1586 to 2044 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AI833267 colon .b 1591 to 2032 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
AA253169 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1593 to 1968 377 to 1       377/377
(100 %)
6 diff
(98.5 %id)
AI378239 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1596 to 2052 465 to 9       457/465
(98 %)
0 diff
(100 %id)
AI376610 pooled .b 1596 to 2046 458 to 8       451/458
(98 %)
0 diff
(100 %id)
AI392802 B-cell, chronic lymphotic leukemia .b 1596 to 2046 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
R54206 whole brain .b 1605 to 2046 457 to 5       453/470
(96 %)
0 diff
(100 %id)
AI934301 adenocarcinoma, Pancreas .b 1615 to 2045 441 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
N33779 melanocyte .b 1616 to 1971 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
AI278319 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1616 to 2046 433 to 3       431/433
(99 %)
0 diff
(100 %id)
AA176252   .b 1619 to 2049 430 to 1   fully sequenced,   430/430
(100 %)
4 diff
(99.1 %id)
AW877681 pnet .b 1622 to 1955 337 to 6       332/338
(98 %)
0 diff
(100 %id)
AI638617 pooled germ cell tumors .b 1625 to 2046 425 to 4       422/425
(99 %)
0 diff
(100 %id)
BM681096 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1625 to 1968 362 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 344/344
(100 %)
0 diff
(100 %id)
BQ333458 pnet .b 1629 to 1948 7 to 333       327/339
(96 %)
22 diff
(93.6 %id)
AW877709 pnet .b 1635 to 1949 12 to 326       315/328
(96 %)
3 diff
(99.1 %id)
AA835548 Spleen .b 1635 to 2046 417 to 6       412/417
(98 %)
0 diff
(100 %id)
AW439073 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1636 to 2046 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AI423607 brain, glioblastoma (pooled) .b 1637 to 1973 337 to 1       337/337
(100 %)
0 diff
(100 %id)
AW877569 pnet .b 1642 to 1951 1 to 315       315/315
(100 %)
17 diff
(94.7 %id)
AW797316 uterus .b 1644 to 1959 317 to 2       316/317
(99 %)
0 diff
(100 %id)
AW877722 pnet .b 1644 to 1786 1 to 143       143/143
(100 %)
0 diff
(100 %id)
AW877683 pnet .b 1650 to 1951 1 to 304       304/304
(100 %)
12 diff
(96.1 %id)
AA600045 bone marrow stroma .b 1655 to 2016 362 to 1       362/362
(100 %)
1 diff
(99.8 %id)
AW877613 pnet .b 1658 to 1951 1 to 297       297/297
(100 %)
14 diff
(95.3 %id)
AA972204 pooled .b 1666 to 2045 380 to 1       380/380
(100 %)
0 diff
(100 %id)
BU536081 mixed (pool of 40 RNAs) .b 1674 to 2042 1 to 369       369/407
(90 %)
2 diff
(99.6 %id)
BQ029630 lung, Metastatic Chondrosarcoma .b 1681 to 2045 383 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
AW877623 pnet .b 1683 to 1951 12 to 281       270/281
(96 %)
6 diff
(97.9 %id)
BE041659 carcinoid, lung .b 1684 to 1967 285 to 1       285/285
(100 %)
3 diff
(99.0 %id)
AI125579   .b 1686 to 2045 376 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 360/360
(100 %)
0 diff
(100 %id)
AW877692 pnet .b 1689 to 1964 1 to 275       275/281
(97 %)
6 diff
(97.9 %id)
AA449761   .b 1691 to 2048 358 to 1   fully sequenced,   358/358
(100 %)
2 diff
(99.5 %id)
AA194016 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1694 to 1973 283 to 2       282/283
(99 %)
0 diff
(100 %id)
AI912941 Kidney .b 1700 to 2046 353 to 7       347/353
(98 %)
0 diff
(100 %id)
BF431238 Kidney .b 1709 to 2046 345 to 8       338/345
(97 %)
0 diff
(100 %id)
AA864484 Kidney, kidney tumor .b 1710 to 2016 307 to 1       307/307
(100 %)
0 diff
(100 %id)
AW877675 pnet .b 1712 to 1951 1 to 241       241/241
(100 %)
2 diff
(99.2 %id)
DV461354 cochlea, ear .b 1730 to 1957 1 to 228       228/228
(100 %)
5 diff
(97.9 %id)
AA548100 germ cell tumor .b 1738 to 2046 310 to 2       309/310
(99 %)
0 diff
(100 %id)
AW183299 pooled .b 1743 to 2044 305 to 1       305/305
(100 %)
3 diff
(99.1 %id)
AA176218   .b 1744 to 2048 309 to 1   fully sequenced,   309/309
(100 %)
2 diff
(99.4 %id)
AA985605 Kidney, kidney tumor .b 1749 to 2016 268 to 1       268/268
(100 %)
0 diff
(100 %id)
F10770 brain, total brain .b 1751 to 2045 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AV736723 cord Blood .b 1766 to 2044 55 to 332   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 278/332
(83 %)
6 diff
(98.2 %id)
CA414127 Chondrosarcoma Grade II, Left Pelvis .b 1769 to 2045 295 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 277/285
(97 %)
0 diff
(100 %id)
AA593958 colon, colon tumor RER+ .b 1781 to 2044 263 to 1       263/263
(100 %)
1 diff
(99.7 %id)
AW771302 Kidney .b 1789 to 2045 273 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 257/257
(100 %)
1 diff
(99.7 %id)
AI696331 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1792 to 2045 278 to 25   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 254/254
(100 %)
1 diff
(99.7 %id)
C01829   .b 1808 to 2045 1 to 238       238/238
(100 %)
0 diff
(100 %id)
W31711 parathyroid gland, parathyroid tumor .b 1843 to 2045 203 to 1       203/203
(100 %)
0 diff
(100 %id)
AI872819 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1854 to 2046 193 to 1       193/193
(100 %)
0 diff
(100 %id)
AI872829 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1855 to 2046 191 to 1       191/191
(100 %)
1 diff
(99.5 %id)
EC548690 Prostate .b 1874 to 1982 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
EC562080 Prostate .b 1876 to 1967 1 to 89       89/90
(98 %)
4 diff
(95.6 %id)
NM_019610.5   .c 1 to 4986 1 to 4986 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4986/4986
(100 %)
0 diff
(100 %id)
DA937852 Spleen .c 164 to 742 8 to 586   tiling clone, capped   579/579
(100 %)
1 diff
(99.9 %id)
AL832554 brain .c 182 to 4986 36 to 4839 K30Q Y31I G32W R33T I34N ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4804/4839
(99 %)
8 diff
(99.9 %id)
DA390224 thalamus .c 186 to 779 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA749181   .c 202 to 772 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CR997396 T-Lymphocytes .c 202 to 936 1 to 744       744/744
(100 %)
6 diff
(99.2 %id)
DB226839 trachea .c 217 to 785 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
CT001205 T-Lymphocytes .c 238 to 1104 1 to 870       870/879
(98 %)
4 diff
(99.6 %id)
BX424223 T cells (Jurkat cell line) .c 245 to 1259 1 to 1005       1005/1011
(99 %)
22 diff
(97.9 %id)
DB230012 trachea .c 298 to 883 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB292055 uterus .c 306 to 901 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA186453 amygdala .c 333 to 878 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
DA720795   .c 333 to 907 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA726029   .c 333 to 892 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB218198 trachea .c 333 to 744 2 to 414   capped   413/424
(97 %)
2 diff
(99.6 %id)
DB035565 testis .c 340 to 895 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BC012942 Eye, retinoblastoma .c 342 to 4004 1 to 3663 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 3663/3663
(100 %)
1 diff
(100.0 %id)
DB067499 testis .c 350 to 903 2 to 556   capped   555/556
(99 %)
2 diff
(99.7 %id)
BE782876 eye, retinoblastoma .c 353 to 1032 1 to 688       688/1088
(63 %)
28 diff
(97.5 %id)
DB218072 trachea .c 363 to 936 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BX424222 T cells (Jurkat cell line) .c 1433 to 2429 1002 to 11   tiling clone,   992/1019
(97 %)
0 diff
(100 %id)
NM_001162536.2   .d 1 to 5086 1 to 5086 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 5086/5086
(100 %)
0 diff
(100 %id)
BP236977 coronary artery .d 158 to 738 1 to 580       580/582
(99 %)
25 diff
(95.8 %id)
DA216732 brain .d 160 to 693 2 to 535   tiling clone, capped   534/534
(100 %)
1 diff
(99.9 %id)
DA219445 brain .d 162 to 716 2 to 557   capped, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 556/559
(99 %)
2 diff
(99.7 %id)
DA800225 brain .d 186 to 733 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA184652 amygdala .d 197 to 686 2 to 491   capped   490/490
(100 %)
1 diff
(99.8 %id)
BX418820 brain, fetal brain .d 202 to 1143 1 to 943       943/967
(97 %)
34 diff
(96.5 %id)
DA566478 heart .d 217 to 781 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA461801 tongue, tumor tissue .d 221 to 720 2 to 501   capped   500/501
(99 %)
1 diff
(99.9 %id)
DB238928 trachea .d 254 to 827 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ421290 melanotic melanoma, skin .d 259 to 1069 1 to 821       821/931
(88 %)
17 diff
(98.2 %id)
BM552015 leiomyosarcoma, uterus .d 319 to 1053 1 to 739       739/1046
(70 %)
18 diff
(98.3 %id)
DA153037 amygdala .d 333 to 892 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA337579 hippocampus .d 333 to 918 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
AU143282   .d 340 to 1082 2 to 745   capped   744/744
(100 %)
9 diff
(98.8 %id)
BE567094 bladder, carcinoma, cell line .d 350 to 897 1 to 552   AAA   552/779
(70 %)
21 diff
(97.4 %id)
BQ435441 leiomyosarcoma, uterus .d 352 to 1192 1 to 852       852/853
(99 %)
11 diff
(98.8 %id)
DB239226 trachea .d 354 to 949 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
FN163850 breast carcinoma .d 484 to 591 107 to 1     Submitted on the opposite strand 107/107
(100 %)
5 diff
(95.4 %id)
AA902664 pooled germ cell tumors .d 594 to 712 119 to 1       119/119
(100 %)
1 diff
(99.2 %id)
DB243253 stomach, tumor tissue .d 597 to 1168 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
BE781751 eye, retinoblastoma .d 605 to 1265 1 to 681       681/834
(81 %)
39 diff
(95.4 %id)
DA446511 tongue, tumor tissue .d 716 to 1302 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB160876 thymus .d 718 to 1298 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BM833891 stomach .d 782 to 1381 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
CR749086 melanotic melanoma, skin .d 802 to 1302 11 to 511       501/511
(98 %)
6 diff
(98.9 %id)
BQ431304 melanotic melanoma, skin .d 804 to 1657 1 to 859       859/859
(100 %)
6 diff
(99.4 %id)
DA801536 brain .d 805 to 1269 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
DA801584 brain .d 805 to 1289 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
DA801590 brain .d 805 to 1294 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DA801595 brain .d 805 to 1293 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
DA801602 brain .d 805 to 1294 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DA801610 brain .d 805 to 1298 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DA787462 brain .d 834 to 1418 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
AW672890 cervix .d 1016 to 1281 1 to 266       266/266
(100 %)
12 diff
(95.5 %id)
DA378884 thalamus .d 1037 to 1598 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL832785 lymph node .d 1157 to 5086 1 to 3927   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 3927/3927
(100 %)
6 diff
(99.9 %id)
BE867589 adenocarcinoma, colon .d 1196 to 1785 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
DA237438 brain .d 1366 to 1950 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
TI_1948126521.
matches multiple genes
  .d 1368 to 1888 680 to 149   tiling clone, also hits gene RBMXP2 532/1288
(41 %)
0 diff
(100 %id)
DB384583   .d 1378 to 1931 554 to 1       554/556
(99 %)
5 diff
(99.2 %id)
AW352370 head_neck .d 1476 to 1635 163 to 3       161/163
(98 %)
0 diff
(100 %id)
TI_154036385   .d 1502 to 2437 948 to 36       913/1012
(90 %)
0 diff
(100 %id)
BX497775 Liver .d 1533 to 1870 1 to 338       338/338
(100 %)
11 diff
(96.8 %id)
BU155489 melanotic melanoma, skin .d 1558 to 2437 1 to 881       881/883
(99 %)
6 diff
(99.4 %id)
BX412789 brain, fetal brain .d 1635 to 2175 542 to 1       542/720
(75 %)
32 diff
(95.6 %id)
BM979682 lung, Primary Lung Epithelial Cells .d 1640 to 2076 455 to 18   AAA   438/438
(100 %)
15 diff
(96.6 %id)
BX500374 Liver .d 1703 to 2226 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
BQ213017 embryonal carcinoma, cell line, testis .d 1720 to 2559 1 to 843   tiling clone,   843/843
(100 %)
3 diff
(99.7 %id)
BI225914 Burkitt lymphoma, lymph .d 1805 to 1890 708 to 796       662/799
(82 %)
72 diff
(91.0 %id)
BF901720 marrow .d 1845 to 2272 1 to 437       437/437
(100 %)
8 diff
(98.2 %id)
DB479579 hippocampus .d 1855 to 2231 1 to 378       378/378
(100 %)
14 diff
(96.3 %id)
BF831961 head_neck .d 2024 to 2205 1 to 182       182/182
(100 %)
1 diff
(99.5 %id)
DA347790 substantia nigra .d 2084 to 2513 146 to 574   capped   429/573
(74 %)
6 diff
(99.0 %id)
BE765521 nervous_tumor .d 2162 to 2405 259 to 18       242/259
(93 %)
5 diff
(98.1 %id)
BE827981 lung_tumor .d 2164 to 2391 227 to 1       227/229
(99 %)
3 diff
(98.7 %id)
BU199271   .d 2185 to 2801 1 to 617       617/859
(71 %)
15 diff
(98.3 %id)
AA427639.
matches multiple genes
ovarian tumor, ovary .d 2203 to 2586 385 to 3     also hits gene RBMXandSNORD61 383/385
(99 %)
0 diff
(100 %id)
BM662171.
matches multiple genes
eye, human retina .d 2223 to 2546 323 to 1     also hits gene RBMXandSNORD61 323/329
(98 %)
15 diff
(95.5 %id)
CA950655 Pancreas, Purified pancreatic islet .d 2339 to 2855 1 to 517       517/517
(100 %)
2 diff
(99.7 %id)
CN311385 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 2385 to 2793 1 to 409       409/409
(100 %)
3 diff
(99.3 %id)
R61126 whole brain .d 2419 to 2730 1 to 315       315/319
(98 %)
6 diff
(98.2 %id)
BP360471 thalamus .d 2440 to 3021 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
F13178 brain, total brain .d 2535 to 2854 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
T77021 whole brain .d 2562 to 3034 1 to 485       485/488
(99 %)
17 diff
(96.6 %id)
CN311384 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 2583 to 3286 1 to 703       703/704
(99 %)
2 diff
(99.8 %id)
BG620806 placenta .d 2774 to 3441 1 to 667       667/668
(99 %)
7 diff
(99.0 %id)
BX956989   .d 2812 to 3485 1 to 674       674/674
(100 %)
0 diff
(100 %id)
BM724417 eye, fetal eye .d 2853 to 3502 1 to 650   fully sequenced,   650/650
(100 %)
0 diff
(100 %id)
AA420790   .d 3018 to 3478 1 to 461       461/461
(100 %)
4 diff
(99.2 %id)
AA397402   .d 3018 to 3533 1 to 512       512/573
(89 %)
15 diff
(97.4 %id)
BF793516 adrenal cortex carcinoma, cell line, adrenal gland .d 3064 to 3827 1 to 760       760/843
(90 %)
16 diff
(98.2 %id)
BI667108 brain, hypothalamus .d 3175 to 3859 1 to 695       695/782
(88 %)
21 diff
(97.4 %id)
TI_44342622   .d 3175 to 3859 120 to 814       695/901
(77 %)
6 diff
(99.4 %id)
AL601261   .d 3224 to 3427 1 to 204       204/204
(100 %)
2 diff
(99.1 %id)
BP228055   .d 3332 to 3896 1 to 566   tiling clone,   566/566
(100 %)
2 diff
(99.7 %id)
BP339008 Spleen .d 3386 to 3834 1 to 450       450/579
(77 %)
5 diff
(99.2 %id)
BU741678 eye, fetal eye .d 3472 to 4122 652 to 1   fully sequenced,   652/652
(100 %)
4 diff
(99.4 %id)
AI971694 pooled germ cell tumors .d 3512 to 4104 594 to 1       594/594
(100 %)
4 diff
(99.4 %id)
AI652463 pooled germ cell tumors .d 3548 to 4107 560 to 1       560/560
(100 %)
0 diff
(100 %id)
R25361 placenta .d 3565 to 3919 1 to 370       370/385
(96 %)
20 diff
(94.9 %id)
BF111167 carcinoid, lung .d 3590 to 4107 518 to 1       518/518
(100 %)
3 diff
(99.5 %id)
AW181890 pooled .d 3599 to 4103 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AI492160 B-cell, chronic lymphotic leukemia .d 3606 to 4115 510 to 1       510/510
(100 %)
0 diff
(100 %id)
AI912000 carcinoid, lung .d 3619 to 4103 485 to 1       485/485
(100 %)
3 diff
(99.4 %id)
AI825229 pooled germ cell tumors .d 3637 to 4104 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AI655283 pooled germ cell tumors .d 3640 to 4105 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AW206820   .d 3666 to 4104 456 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 439/439
(100 %)
1 diff
(99.8 %id)
CR743094 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 3668 to 4118 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
DB548289 hippocampus .d 3679 to 4104 1 to 425     Submitted on the opposite strand 425/425
(100 %)
1 diff
(99.8 %id)
AA420728   .d 3715 to 4104 412 to 23   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 390/390
(100 %)
5 diff
(98.8 %id)
CD103884 Pooled-Skin .d 3745 to 4385 1 to 651       651/765
(85 %)
14 diff
(98.2 %id)
BG941852 blood .d 3755 to 4104 1 to 350   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 350/350
(100 %)
1 diff
(99.8 %id)
AI538911 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 3773 to 4104 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AI916051 colon, colon tumor, RER+ .d 3774 to 4103 331 to 1       331/331
(100 %)
1 diff
(99.7 %id)
AW779089 pooled .d 3783 to 4105 323 to 1       323/323
(100 %)
2 diff
(99.4 %id)
F10785 brain, total brain .d 3790 to 4104 315 to 1       315/315
(100 %)
0 diff
(100 %id)
R61845 whole brain .d 3803 to 4113 315 to 1       315/315
(100 %)
4 diff
(98.8 %id)
R38100 whole brain .d 3805 to 4112 309 to 1       309/309
(100 %)
3 diff
(99.1 %id)
BU160355 melanotic melanoma, skin .d 3828 to 4646 24 to 846       823/899
(91 %)
7 diff
(99.3 %id)
BE935969 nervous_normal .d 3921 to 4405 1 to 481       481/492
(97 %)
17 diff
(96.6 %id)
BE699181 nervous_normal .d 3922 to 4446 1 to 524       524/524
(100 %)
25 diff
(95.3 %id)
BE935995 nervous_normal .d 3935 to 4460 1 to 527       527/529
(99 %)
52 diff
(90.2 %id)
R67202 whole brain .d 3968 to 4105 1 to 138       138/138
(100 %)
0 diff
(100 %id)
AA723937 pooled .d 4015 to 4359 1 to 345     Submitted on the opposite strand 345/345
(100 %)
1 diff
(99.8 %id)
CA950415 Pancreas, Purified pancreatic islet .d 4093 to 4471 382 to 4       379/382
(99 %)
0 diff
(100 %id)
D31130   .d 4111 to 4400 1 to 290       290/290
(100 %)
1 diff
(99.7 %id)
BQ269427 Pancreas, Purified pancreatic islet .d 4124 to 4588 1 to 465   fully sequenced,   465/465
(100 %)
5 diff
(99.0 %id)
W21106 lung .d 4129 to 4396 1 to 270       270/274
(98 %)
4 diff
(98.6 %id)
BE937978 testis_normal .d 4130 to 4342 232 to 19       214/232
(92 %)
0 diff
(100 %id)
T20047   .d 4132 to 4386 1 to 255       255/256
(99 %)
11 diff
(95.8 %id)
R28498 placenta .d 4135 to 4628 1 to 503       503/509
(98 %)
33 diff
(93.6 %id)
AA328596   .d 4137 to 4443 1 to 307       307/307
(100 %)
0 diff
(100 %id)
AW962402   .d 4138 to 4742 1 to 613       613/616
(99 %)
25 diff
(96.0 %id)
TI_149307402   .d 4152 to 5086 1031 to 109   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 923/993
(92 %)
34 diff
(96.6 %id)
W21563 lung .d 4166 to 4291 1 to 126       126/126
(100 %)
0 diff
(100 %id)
BI335845 skin .d 4168 to 4474 307 to 1       307/307
(100 %)
0 diff
(100 %id)
BF573387 melanotic melanoma, high MDR, skin .d 4211 to 4847 1 to 619       619/855
(72 %)
14 diff
(98.4 %id)
T20048   .d 4213 to 4473 268 to 5       264/274
(96 %)
0 diff
(100 %id)
BE892879 melanotic melanoma, skin .d 4259 to 4867 1 to 611       611/918
(66 %)
3 diff
(99.7 %id)
TI_154127253   .d 4293 to 5086 891 to 108   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 784/939
(83 %)
11 diff
(98.9 %id)
BU621217 cell lines, Chondrosarcoma .d 4374 to 5086 731 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 713/713
(100 %)
1 diff
(99.9 %id)
CA416985 Chondrosarcoma Cell line .d 4412 to 5086 688 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 675/675
(100 %)
0 diff
(100 %id)
BM803137 duodenal adenocarcinoma, cell line, small intestine .d 4435 to 5086 1 to 652       652/652
(100 %)
0 diff
(100 %id)
BM979196 lung, Primary Lung Epithelial Cells .d 4436 to 5086 664 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 651/651
(100 %)
3 diff
(99.6 %id)
TI_151736223   .d 4475 to 5051 704 to 128       577/1143
(50 %)
0 diff
(100 %id)
BF673916 Prostate .d 4496 to 5087 42 to 639       598/710
(84 %)
59 diff
(91.7 %id)
AI742713 pooled .d 4506 to 5081 600 to 25   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
AW188025 pooled .d 4506 to 5087 582 to 1       582/582
(100 %)
0 diff
(100 %id)
AW182335 pooled .d 4530 to 5089 566 to 7   tiling clone,   560/566
(98 %)
0 diff
(100 %id)
AI633605 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 4531 to 5087 560 to 4       557/560
(99 %)
0 diff
(100 %id)
BQ286069 Pancreas, Purified pancreatic islet .d 4558 to 5089 532 to 1   fully sequenced,   532/532
(100 %)
1 diff
(99.9 %id)
AA948351 2 pooled tumors (clear cell type), Kidney .d 4573 to 5087 517 to 5       513/517
(99 %)
0 diff
(100 %id)
AI688660 pooled .d 4575 to 5084 510 to 1       510/510
(100 %)
1 diff
(99.9 %id)
AA868973   .d 4596 to 5087 495 to 3       493/495
(99 %)
0 diff
(100 %id)
AA809354 germinal center B cell .d 4597 to 5086 500 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 490/490
(100 %)
0 diff
(100 %id)
DB522758 testis .d 4617 to 5086 1 to 470     Submitted on the opposite strand 470/470
(100 %)
1 diff
(99.8 %id)
AI092704 parathyroid gland, parathyroid tumor .d 4622 to 5087 472 to 7       466/472
(98 %)
0 diff
(100 %id)
AA345640 gall bladder .d 4623 to 4905 1 to 283       283/292
(96 %)
3 diff
(99.0 %id)
AW182572 pooled .d 4630 to 5087 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
AA714536 germinal center B-cells, tonsil .d 4631 to 5088 472 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 456/456
(100 %)
5 diff
(99.0 %id)
AI982576 pooled germ cell tumors .d 4639 to 5086 467 to 20   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 448/448
(100 %)
1 diff
(99.8 %id)
BX090449   .d 4657 to 5086 1 to 430   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 430/430
(100 %)
2 diff
(99.6 %id)
AA453378   .d 4657 to 5086 1 to 428   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 428/428
(100 %)
11 diff
(97.5 %id)
AA857887 colon, colon tumor .d 4681 to 5086 417 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 406/406
(100 %)
0 diff
(100 %id)
AW268630 pooled .d 4681 to 5087 409 to 3       407/409
(99 %)
0 diff
(100 %id)
BF431651 Kidney .d 4689 to 5087 399 to 1       399/399
(100 %)
3 diff
(99.3 %id)
AI540251 lymph node, lymphoma, follicular mixed small and largecell .d 4734 to 5086 366 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
AW015596   .d 4740 to 5086 362 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 347/347
(100 %)
0 diff
(100 %id)
AW085936 ovary, papillary serous carcinoma .d 4755 to 5084 358 to 29       330/358
(92 %)
0 diff
(100 %id)
AI674994 Prostate .d 4765 to 5087 323 to 1       323/323
(100 %)
0 diff
(100 %id)
N92899 lung .d 4805 to 5087 285 to 2       284/285
(99 %)
0 diff
(100 %id)
AI985448 Kidney .d 4814 to 5087 284 to 11       274/284
(96 %)
0 diff
(100 %id)
AI024158   .d 4839 to 5086 265 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 248/248
(100 %)
0 diff
(100 %id)
AI990585 pooled germ cell tumors .d 4849 to 5088 240 to 1       240/240
(100 %)
0 diff
(100 %id)
BF056773 pooled germ cell tumors .d 4849 to 5089 243 to 1       243/243
(100 %)
2 diff
(99.2 %id)
AI220009 pooled .d 4851 to 5087 238 to 2       237/238
(99 %)
0 diff
(100 %id)
AI928573 anaplastic oligodendroglioma, brain .d 4877 to 5089 226 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 213/214
(99 %)
0 diff
(100 %id)
AA453280   .d 4896 to 5084 218 to 31   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 188/188
(100 %)
0 diff
(100 %id)
R60009 whole brain .d 4962 to 5090 143 to 16       128/143
(89 %)
0 diff
(100 %id)
BM478786 embryonal carcinoma, cell line, testis .e 1 to 894 4 to 898   tiling clone,   898/1082
(82 %)
10 diff
(99.1 %id)
DC420179 uterus .e 15 to 573 1 to 559       559/559
(100 %)
0 diff
(100 %id)
AL541555 placenta .e 71 to 1020 1 to 951   tiling clone, to resequence,   951/951
(100 %)
2 diff
(99.8 %id)
AL541554 placenta .e 1164 to 2161 994 to 1   tiling clone, to resequence,   994/994
(100 %)
11 diff
(98.9 %id)
DC397356 testis .f 1 to 537 4 to 540   tiling clone,   540/540
(100 %)
4 diff
(99.3 %id)
AL833593 human endometrium .f 203 to 2072 1 to 1870 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1870/1870
(100 %)
3 diff
(99.9 %id)
DA385938 thalamus .f 364 to 909 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA943114 Spleen .g 1 to 595 2 to 597   tiling clone, capped   596/596
(100 %)
2 diff
(99.7 %id)
BE780818 eye, retinoblastoma .g 42 to 912 1 to 744 F67L G68A H69I P70H S71H ... tiling clone, Suspected internal deletion 744/857
(86 %)
21 diff
(97.6 %id)
AA311510   .h 1 to 329 5 to 333   tiling clone,   333/333
(100 %)
0 diff
(100 %id)
AW965762   .h 6 to 570 1 to 559       559/560
(99 %)
11 diff
(98.1 %id)
CB266214 adipose .h 189 to 755 11 to 573 exact tiling clone,   563/573
(98 %)
6 diff
(99.0 %id)
CN255371 embryonic stem cells, DMSO-treated H9 cellline .i 1 to 610 1 to 612   tiling clone,   612/612
(100 %)
2 diff
(99.7 %id)
AI826098 anaplastic oligodendroglioma, brain .i 395 to 1018 631 to 8   tiling clone,   624/634
(98 %)
7 diff
(98.9 %id)
R48038 breast .i 498 to 760 1 to 275   fully sequenced,   275/275
(100 %)
11 diff
(96.0 %id)
R73293 breast .i 498 to 756 1 to 261   tiling clone, fully sequenced,   261/261
(100 %)
0 diff
(100 %id)
R73304 breast .i 498 to 756 2 to 260   fully sequenced,   259/260
(99 %)
0 diff
(100 %id)
AI498418 Kidney .i 533 to 1011 478 to 1   tiling clone,   478/478
(100 %)
9 diff
(98.2 %id)
AI910701 Kidney .i 557 to 1009 452 to 3       450/452
(99 %)
4 diff
(99.2 %id)
AA780950   .i 567 to 991 425 to 1       425/426
(99 %)
2 diff
(99.6 %id)
AI123725 pooled .i 575 to 1011 457 to 21   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 437/437
(100 %)
3 diff
(99.4 %id)
R72835 breast .i 726 to 997 283 to 12   fully sequenced,   272/283
(96 %)
0 diff
(100 %id)
R72844 breast .i 726 to 1008 284 to 1   fully sequenced,   284/284
(100 %)
2 diff
(99.3 %id)
R47930 breast .i 730 to 1007 286 to 1   fully sequenced,   286/286
(100 %)
3 diff
(99.0 %id)
BQ023904 placenta .i 769 to 1007 257 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 239/239
(100 %)
0 diff
(100 %id)
AW385260 leiomios .j 1 to 524 524 to 2   tiling clone,   523/524
(99 %)
0 diff
(100 %id)
CN255374 embryonic stem cells, DMSO-treated H9 cellline .j 302 to 996 9 to 703 exact tiling clone,   695/703
(98 %)
6 diff
(99.2 %id)
TI_149278403   .j 349 to 1158 895 to 90 D3P P4R E5C C6T Y7L ... AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 806/1092
(73 %)
17 diff
(98.5 %id)
BQ027052 Chondrosarcoma, Left Pubic Bone .j 368 to 1084 733 to 19 Y7T F8L N9I S10F L11A ... AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
BE541873 cervix .j 369 to 1105 1 to 725 L11C P12Q E14S L15*     725/899
(80 %)
27 diff
(97.0 %id)
AA868310   .j 444 to 1159 718 to 3   tiling clone,   716/718
(99 %)
19 diff
(97.4 %id)
AW027807 Kidney .j 450 to 1082 635 to 3       633/635
(99 %)
5 diff
(99.3 %id)
AW085516 pooled .j 458 to 1081 637 to 13   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 625/627
(99 %)
12 diff
(98.1 %id)
BG055444 carcinoid, lung .j 463 to 1080 622 to 5       618/629
(98 %)
5 diff
(99.3 %id)
BG938444 Bone, Hip .j 474 to 1101 633 to 6       628/633
(99 %)
0 diff
(100 %id)
BU678475 lung .j 475 to 1158 702 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
AI677723 pooled .j 477 to 1159 684 to 4       683/689
(99 %)
18 diff
(97.4 %id)
AW130338 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 478 to 1082 609 to 1       609/609
(100 %)
6 diff
(99.1 %id)
AA928284 pooled .j 486 to 1158 673 to 1       673/673
(100 %)
38 diff
(94.4 %id)
AW590774 pooled germ cell tumors .j 492 to 1158 667 to 1       667/667
(100 %)
12 diff
(98.3 %id)
AW612478 Kidney .j 498 to 1159 666 to 5       662/666
(99 %)
0 diff
(100 %id)
BF431208 Kidney .j 501 to 1158 658 to 1       658/658
(100 %)
3 diff
(99.6 %id)
CN285092 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k-u 1 to 757 1 to 755   tiling clone,   755/755
(100 %)
4 diff
(99.5 %id)
AW848423 colon .k-u 248 to 794 1 to 547       547/547
(100 %)
3 diff
(99.5 %id)
BX108949 liver and spleen .k-u 591 to 1370 1 to 781 W110C tiling clone,   781/781
(100 %)
5 diff
(99.4 %id)
H73333 liver and spleen .k-u 616 to 986 1 to 378   to resequence,   378/378
(100 %)
7 diff
(98.2 %id)
BX507001 Liver .k-u 688 to 1226 1 to 541 Q5H L6V L7I P8T M9N ...     541/541
(100 %)
8 diff
(98.6 %id)
BF926023 nervous_tumor .k-u 728 to 1045 326 to 11     Submitted on the opposite strand 316/354
(89 %)
0 diff
(100 %id)
BF110816 carcinoid, lung .k-u 1716 to 2222 507 to 1   tiling clone,   507/507
(100 %)
1 diff
(99.9 %id)
BF110977 carcinoid, lung .k-u 1717 to 2222 508 to 1   tiling clone,   508/508
(100 %)
4 diff
(99.3 %id)
H73972 liver and spleen .k-u 1794 to 2218 441 to 2   to resequence,   440/489
(89 %)
0 diff
(100 %id)
AI080222 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 1821 to 2219 399 to 1       399/399
(100 %)
0 diff
(100 %id)
BE466944 carcinoid, lung .k-u 1827 to 2218 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AL709359 human skeletal muscle .k-u 2180 to 2847 669 to 1   tiling clone, Submitted on the opposite strand 669/669
(100 %)
1 diff
(99.9 %id)
CX786659 human embryonic stem cells .l-u 1 to 826 1 to 825 L27* tiling clone,   825/825
(100 %)
4 diff
(99.6 %id)
BX501587 Liver .m-u 1 to 550 1 to 550   tiling clone,   550/550
(100 %)
0 diff
(100 %id)
AI355986 brain, glioblastoma (pooled) .m-u 319 to 663 345 to 1 exact tiling clone,   345/345
(100 %)
1 diff
(99.8 %id)
AA382334 testis .n 1 to 258 2 to 261 exact tiling clone,   261/261
(100 %)
3 diff
(98.9 %id)
BF086869 placenta_normal .o-u 1 to 207 1 to 205 W2R D9E L18C P19Q E21S ... tiling clone,   205/214
(95 %)
6 diff
(97.2 %id)
AV648806 corresponding non cancerous liver tissue Gene CCBL2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB320187   Gene CCBL2, variant not shown         This clone was ignored    
DA619411   Gene CCBL2, variant not shown       capped This clone was ignored    
BE078179 breast Gene CCBL2, variant not shown         Submitted on the opposite strand    
BP277197 Kidney Gene CCBL2, variant not shown         Suspected internal deletion, this clone was ignored    
CN314985 embryonic stem cells, cell lines H1, H7, andH9 Gene CCBL2, variant not shown         This clone was ignored    
CR627392 fetal kidney Gene CCBL2, variant not shown       available from DKFZ, AAA This clone was ignored    
BX093739 heart Gene CCBL2, variant not shown       AAA This clone was ignored    
DB298068 cerebellum Gene CCBL2, variant not shown         This clone was ignored    
DA085011 cerebellum Gene CCBL2, variant not shown       capped This clone was ignored    
AA233566 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene CCBL2, variant not shown         This clone was ignored    
AA233678 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene CCBL2, variant not shown         This clone was ignored    
AA252044 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene CCBL2, variant not shown       fully sequenced,      
AA252062 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene CCBL2, variant not shown       fully sequenced,      
AI140843 heart Gene CCBL2, variant not shown         This clone was ignored    
AI126907 heart Gene CCBL2, variant not shown         This clone was ignored    
AI522260 Kidney Gene CCBL2, variant not shown              
AI927698 Kidney Gene CCBL2, variant not shown              
AW505110 lymph Gene CCBL2, variant not shown         Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base)    
AW576553 lymph Gene CCBL2, variant not shown       AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base)    
BE879391 large cell carcinoma, undifferentiated, lung Gene CCBL2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154134395   Gene CCBL2, variant not shown       AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base)    
TI_154161616   Gene CCBL2, variant not shown              
DB218339 trachea Gene CCBL2, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m-u, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI